TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Female
KW - Focus Groups
KW - Health Knowledge, Attitudes, Practice
KW - Health Services Accessibility
KW - Humans
KW - Male
KW - Opiate Substitution Treatment/psychology
KW - Patient Acceptance of Health Care/psychology
KW - Qualitative Research
KW - medication-assisted treatment
KW - opioid use
KW - policy
KW - Treatment-seeking
AU - Valerie M. Hewell
AU - Angel R. Vasquez
AU - Inna D. Rivkin
A1 - 
AB - BACKGROUND: Opioid use is a significant problem in Alaska. Medication-assisted treatment for opioid use, including buprenorphine, reduces withdrawal symptoms and the harm associated with opioid abuse. Understanding consumers' treatment-seeking process is important for addressing barriers to treatment, facilitating effective service utilization, and informing policy. METHODS: To understand treatment-seeking behavior, we examined the attitudes, perceptions, and knowledge of those who would benefit from the medication-assisted treatment (MAT) buprenorphine. Qualitative data from 2 focus groups (each including 4 participants) and 3 in-depth interviews with people who have used or considered using buprenorphine in treatment for an opioid use disorder were analyzed using grounded theory and directed content analysis approaches. RESULTS: Key findings suggest that individual (withdrawal process, individual motivation) and systemic (sociocultural, political, societal values) factors frame the treatment seeking process. Participants' progress on the treatment-seeking road was affected by models of addiction and MAT, which related to facilitators and barriers encountered in seeking treatment (e.g. support, resources, treatment structure). These factors shaped the longer-term road to recovery, which was seen as on ongoing process. CONCLUSIONS: The findings of this study suggest it is crucial for interventionists to take a contextual approach that considers individual and systemic factors involved in opioid addiction, treatment, and recovery. This study highlights ways policy makers and treatment providers can address the barriers consumers face in their treatment-seeking process in order to increase treatment access.
AD - Department of Psychology, University of Alaska Fairbanks, P.O. Box 756480, AK 99775, Fairbanks, USA. dr.valerie.hewell@gmail.com.; Department of Psychology, University of Alaska Fairbanks, P.O. Box 756480, AK 99775, Fairbanks, USA.; Department of Psychology, University of Alaska Fairbanks, P.O. Box 756480, AK 99775, Fairbanks, USA.
BT - Substance abuse treatment, prevention, and policy
C5 - Education & Workforce; Opioids & Substance Use
CP - 1
CY - England
DO - 10.1186/s13011-016-0085-y
IS - 1
JF - Substance abuse treatment, prevention, and policy
LA - eng
M1 - Journal Article
N2 - BACKGROUND: Opioid use is a significant problem in Alaska. Medication-assisted treatment for opioid use, including buprenorphine, reduces withdrawal symptoms and the harm associated with opioid abuse. Understanding consumers' treatment-seeking process is important for addressing barriers to treatment, facilitating effective service utilization, and informing policy. METHODS: To understand treatment-seeking behavior, we examined the attitudes, perceptions, and knowledge of those who would benefit from the medication-assisted treatment (MAT) buprenorphine. Qualitative data from 2 focus groups (each including 4 participants) and 3 in-depth interviews with people who have used or considered using buprenorphine in treatment for an opioid use disorder were analyzed using grounded theory and directed content analysis approaches. RESULTS: Key findings suggest that individual (withdrawal process, individual motivation) and systemic (sociocultural, political, societal values) factors frame the treatment seeking process. Participants' progress on the treatment-seeking road was affected by models of addiction and MAT, which related to facilitators and barriers encountered in seeking treatment (e.g. support, resources, treatment structure). These factors shaped the longer-term road to recovery, which was seen as on ongoing process. CONCLUSIONS: The findings of this study suggest it is crucial for interventionists to take a contextual approach that considers individual and systemic factors involved in opioid addiction, treatment, and recovery. This study highlights ways policy makers and treatment providers can address the barriers consumers face in their treatment-seeking process in order to increase treatment access.
PP - England
PY - 2017
SN - 1747-597X; 1747-597X
SP - 3
T1 - Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study
T2 - Substance abuse treatment, prevention, and policy
TI - Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study
U1 - Education & Workforce; Opioids & Substance Use
U2 - 28086837
U3 - 10.1186/s13011-016-0085-y
VL - 12
VO - 1747-597X; 1747-597X
Y1 - 2017
Y2 - Jan 11
ER -